Navigation Links
LSUHSC's Bazan awarded ARRA grant to preserve vision
Date:7/14/2009

New Orleans, LA Haydee Bazan, PhD, Professor of Ophthalmology at LSU Health Sciences Center New Orleans School of Medicine, has been awarded a $710,000 grant over two years by the National Institutes of Health to advance her research on potential therapeutic approaches to heal corneal injuries. The grant was awarded under the American Recovery and Reinvestment Act.

Dr. Bazan's research project explores the mechanisms of inflammation and repair during corneal wound healing. Sustained corneal inflammation may lead to destruction and corneal ulceration, but inflammation is a component of the corneal wound healing process. There is a critical balance between signaling mechanisms that promote either cellular damage or repair. This balance is fundamental to the maintenance of corneal integrity and function and extensive damage occurs when the equilibrium between chemical messengers (lipid mediators) that are released in response to tissue injury in the cornea is lost. Dr. Bazan's research will focus on several of these mediators platelet-activating factor (PAF) which appears to play a key role contributing to tissue destruction, and the arachidonic acid (AA)- mediators that play a key role in tissue repair. AA-mediators, lipoxin A4 and the aspirin-triggered epi-LxA4, will be studied .

"If our hypothesis is correct, PAF antagonists, and the lipoxins and epi-lipoxins can become effective therapeutic tools for maintaining the transparency and integrity of the cornea," notes Dr. Bazan.

According to the American Academy of Ophthalmology, each year, more than 2.5 million eye injuries occur and 50,000 people permanently lose part or all of their vision.

According to the US Department of Health and Human Services, eye injury is a leading cause of monocular blindness (blindness in one eye) in the United States. In 2004, about 37,000 eye injuries occurred in the workplace that resulted in one or more days away from work. The majority of these eye injuries occurred in workers less than 45 years of age (74%). The majority of all eye injuries occur in persons under 30 years of age (57%). Common causes of occupational eye injury include blunt trauma, chemical burns, corneal abrasions (a scratch on the cornea, the clear dome-shaped surface that covers the front of the eye), and biological contamination (infections).


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related biology news :

1. UTSA psychologist awarded $1 million for memory research
2. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
3. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
4. Ernst-Ludwig Winnacker awarded the Order of the Rising Sun
5. University of Liverpool awarded $3.3 million for genomics hub
6. UCI awarded $45 million for infectious disease research
7. University awarded £1.7M to develop nanotechnology for use in health care
8. LSUHSC student awarded top national honor for diabetes research
9. CSC Awarded $570 Million IT Services Contract by UK Identity and Passport Service
10. Jefferson researcher awarded Landenberger Foundation grant for ALS research
11. CSC Awarded $570 Million IT Services Contract by UK Identity and Passport Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... ... innovative medical technologies, services and solutions to the healthcare market. The company's primary ... various distribution, manufacturing, sales and marketing strategies that are necessary to help companies ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: